Raymond James Financial »

Werewolf Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 14k 1.97
2025-06-30 $14k 13k 1.09

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
MPM Oncology Impact Management
Vanguard Group
Sphera Funds Management
DC Funds
Renaissance Technologies
Partner Fund Management
Geode Capital Management
Millennium Management
Jane Street
Alyeska Investment Group
Citadel Advisors
State Street Corporation
Bridgeway Capital Management

View all funds holding Werewolf Therapeutics